APYX · Apyx Medical Corp
United States · RS rating 10 · As of 2026-10-14
| Price | 2.57 USD |
|---|---|
| 1-day change | -1.1% |
| RS rating (overall / 1M / 3M / 12M) | 10 / 18 / 7 / 29 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 26 / 7 / 16 |
| Industry group (rank) | Medical-Products (98) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | +48.8% |
| Distance from 52-week high | +47.1% |
| Market cap (USD) | $159.0M |